NCT00655109

A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis

A Comparison of Olopatadine Versus Fluticasone Nasal Spray in the Prevention of the Signs and Symptoms of Allergic Conjunctivitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Greiner, Jack V., OD DO PhD · Individual
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis

Detailed description

Study will evaluate the efficacy of nasal anti-allergic therapy compared to ocular anti-allergic therapy in the prevention of ocular allergic symptoms.

Conditions

• Conjunctivitis, Allergic

Interventions

Type	Name	Description
DRUG	Olopatadine	Ophthalmic solution
DRUG	Fluticasone	Nasal spray
DRUG	Saline	Nasal spray
DRUG	Artificial tears	Ophthalmic Solution

Timeline

• Start date: 2008-02-01
• Primary completion: 2008-03-01
• Completion: 2008-03-01
• First posted: 2008-04-09
• Last updated: 2008-04-09

Locations

1 site across 1 country: United States